These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16514085

  • 1. Kruppel-like factor 2 inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation.
    Lin Z, Hamik A, Jain R, Kumar A, Jain MK.
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1185-9. PubMed ID: 16514085
    [Abstract] [Full Text] [Related]

  • 2. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function.
    Lin Z, Kumar A, SenBanerjee S, Staniszewski K, Parmar K, Vaughan DE, Gimbrone MA, Balasubramanian V, García-Cardeña G, Jain MK.
    Circ Res; 2005 Mar 18; 96(5):e48-57. PubMed ID: 15718498
    [Abstract] [Full Text] [Related]

  • 3. Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1.
    Day JR, Taylor KM, Lidington EA, Mason JC, Haskard DO, Randi AM, Landis RC.
    J Thorac Cardiovasc Surg; 2006 Jan 18; 131(1):21-7. PubMed ID: 16399290
    [Abstract] [Full Text] [Related]

  • 4. Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase C alpha, c-Src, NF-kappa B and p300 pathway.
    Chiu YC, Fong YC, Lai CH, Hung CH, Hsu HC, Lee TS, Yang RS, Fu WM, Tang CH.
    Mol Immunol; 2008 Mar 18; 45(6):1587-99. PubMed ID: 18062909
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1.
    Boon RA, Fledderus JO, Volger OL, van Wanrooij EJ, Pardali E, Weesie F, Kuiper J, Pannekoek H, ten Dijke P, Horrevoets AJ.
    Arterioscler Thromb Vasc Biol; 2007 Mar 18; 27(3):532-9. PubMed ID: 17194892
    [Abstract] [Full Text] [Related]

  • 7. Thrombin-stimulated growth factor and cytokine expression in osteoblasts is mediated by protease-activated receptor-1 and prostanoids.
    Pagel CN, Song SJ, Loh LH, Tudor EM, Murray-Rust TA, Pike RN, Mackie EJ.
    Bone; 2009 May 18; 44(5):813-21. PubMed ID: 19442625
    [Abstract] [Full Text] [Related]

  • 8. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium.
    Rudack C, Steinhoff M, Mooren F, Buddenkotte J, Becker K, von Eiff C, Sachse F.
    Clin Exp Allergy; 2007 Jul 18; 37(7):1009-22. PubMed ID: 17581194
    [Abstract] [Full Text] [Related]

  • 9. Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells.
    Liu J, Schuff-Werner P, Steiner M.
    Biochem Biophys Res Commun; 2006 Apr 28; 343(1):183-9. PubMed ID: 16530725
    [Abstract] [Full Text] [Related]

  • 10. TLR2- and nucleotide-binding oligomerization domain 2-dependent Krüppel-like factor 2 expression downregulates NF-kappa B-related gene expression.
    Zahlten J, Steinicke R, Opitz B, Eitel J, N'guessan PD, Vinzing M, Witzenrath M, Schmeck B, Hammerschmidt S, Suttorp N, Hippenstiel S.
    J Immunol; 2010 Jul 01; 185(1):597-604. PubMed ID: 20525885
    [Abstract] [Full Text] [Related]

  • 11. Thrombin-induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration.
    Popovic M, Laumonnier Y, Burysek L, Syrovets T, Simmet T.
    J Leukoc Biol; 2008 Jul 01; 84(1):215-23. PubMed ID: 18436581
    [Abstract] [Full Text] [Related]

  • 12. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells.
    Sen-Banerjee S, Mir S, Lin Z, Hamik A, Atkins GB, Das H, Banerjee P, Kumar A, Jain MK.
    Circulation; 2005 Aug 02; 112(5):720-6. PubMed ID: 16043642
    [Abstract] [Full Text] [Related]

  • 13. Sphingosine kinase 1 is essential for proteinase-activated receptor-1 signalling in epithelial and endothelial cells.
    Billich A, Urtz N, Reuschel R, Baumruker T.
    Int J Biochem Cell Biol; 2009 Jul 02; 41(7):1547-55. PubMed ID: 19162217
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
    Nishinakamura H, Minoda Y, Saeki K, Koga K, Takaesu G, Onodera M, Yoshimura A, Kobayashi T.
    Int Immunol; 2007 May 02; 19(5):609-19. PubMed ID: 17383969
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of protease-activated receptor-1 in endothelial nitric oxide synthase-Thr495 phosphorylation.
    Watts VL, Motley ED.
    Exp Biol Med (Maywood); 2009 Feb 02; 234(2):132-9. PubMed ID: 19064940
    [Abstract] [Full Text] [Related]

  • 19. Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT.
    Rosenkranz AC, Rauch BH, Freidel K, Schrör K.
    Cardiovasc Res; 2009 Sep 01; 83(4):778-84. PubMed ID: 19460777
    [Abstract] [Full Text] [Related]

  • 20. Key transcriptional regulators of the vasoprotective effects of shear stress.
    Boon RA, Horrevoets AJ.
    Hamostaseologie; 2009 Jan 01; 29(1):39-40, 41-3. PubMed ID: 19151844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.